Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 2A receptor (5-HT2A) is a subtype of the serotonin (5-hydroxytryptamine, 5-HT) receptor family. It is a G protein-coupled receptor (GPCR), specifically coupled to the Gq/11 protein, and is considered the main excitatory serotonin GPCR in the central nervous system. The gene encoding this receptor in humans is HTR2A. It is involved in learning and memory processes, mood regulation, neurogenesis, and cortical function and cognition. Abnormalities or dysregulation are implicated in psychiatric disorders including depression, schizophrenia, drug addiction, and suicidality. Overexpression has been observed in depressed patients; downregulation occurs with chronic SSRI or atypical antipsychotic use.
Agonism, antagonism, inverse agonism
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor Subtype 5-HT2A (None).